Enrique Lores - Dec 7, 2021 Form 4 Insider Report for HP INC (HPQ)

Role
President and CEO, Director
Signature
/s/ Rick Hansen as Attorney-in-Fact for Enrique Lores
Stock symbol
HPQ
Transactions as of
Dec 7, 2021
Transactions value $
-$3,364,490
Form type
4
Date filed
12/9/2021, 05:01 PM
Previous filing
Dec 6, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HPQ Common Stock Options Exercise $0 +191K +34.46% $0.00 743K Dec 7, 2021 Direct
transaction HPQ Common Stock Tax liability -$3.36M -90.2K -12.14% $37.29 653K Dec 7, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HPQ Restricted Stock Units Award +121K 121K Dec 7, 2021 Common Stock 121K Direct F2, F3
transaction HPQ Performance Adjusted Restricted Stock Units Award +108K 108K Dec 7, 2021 Common Stock 108K Direct F4
transaction HPQ Performance Contingent Stock Options Award +499K 499K Dec 7, 2021 Common Stock 499K $37.29 Direct F5
transaction HPQ Restricted Stock Units Options Exercise -78.1K -33.93% 152K Dec 7, 2021 Common Stock 78.1K Direct F2, F6
transaction HPQ Restricted Stock Units Options Exercise -76.3K -51.62% 71.5K Dec 7, 2021 Common Stock 76.3K Direct F2, F7
transaction HPQ Restricted Stock Units Options Exercise -36.1K -100% 0 Dec 7, 2021 Common Stock 36.1K Direct F2, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by HP to satisfy tax withholding upon vesting.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.
F3 On 12/7/2021, the reporting person was granted 120,676 RSUs, one-third of which vest annually over three years on each of 12/7/2022, 12/7/2023 and 12/7/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.
F4 On 12/7/2021, the reporting person was granted 108,441 performance adjusted restricted stock units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/2024, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.
F5 The performance contingent stock options granted on 12/7/2021 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions.
F6 As previously reported, on 12/7/2020, the reporting person was granted 228,041 RSUs, 76,013 of which vested on 12/7/2021 and 76,014 of which is scheduled to vest on each of 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,065 vested dividend equivalent rights.
F7 As previously reported, on 12/6/2019, the reporting person was granted 214,634 RSUs, 71,544 of which vested on 12/7/2020, 71,545 vested on 12/7/2021 and 71,545 of which is scheduled to vest on 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 4,796 vested dividend equivalent rights.
F8 As previously reported, on 12/7/2018, the reporting person was granted 98,561 RSUs, 32,853 of which vested on 12/7/2019, 32,854 of which vested on 12/7/2020 and 32,854 of which vested on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 3,255 vested dividend equivalent rights.